This small biotech could grow much larger with some good news from its pipeline.

PDS Biotech’s stock has jumped nearly 25% after its tumour-targeting fused antibody drug conjugate (ADC) elicited a 78% ...

Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...

View Legend Biotech Corp. Sponsored ADR LEGN stock quote prices, financial information, real-time forecasts, and company news from CNN.

This Boston-based biotech develops therapies for neurological disorders, with a pipeline targeting depression, tremor, and ...

In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now. On April 13, Tom Lee, Fundstrat’s ...

Viking's candidate is part of the GLP-1 class of drugs, which interact with hormonal pathways controlling appetite and blood ...

With an approved treatment in commercial stages and new drug candidates generating clinical trial results, this biotech has ...

Now, it’s worth noting Stock Advisor’s total average return is 930 % — a market-crushing outperformance compared to 185% for ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to continue.

The latest trial milestone sends this ASX biotech stock higher today. The post This ASX biotech stock just jumped again as ...